This is a competitive combined synopsis/solicitation seeking offers for a firm-fixed-price purchase order of commercially available laboratory equipment. The equipment will support NIH/NHLBI research on hematopoietic stem cell-targeted lipid nanoparticle gene delivery for advancing in vivo gene therapy. Offerors must provide equipment meeting or exceeding the stated salient characteristics. The acquisition is unrestricted, uses full and open competition, and is associated with NAICS code 334516 with a 1,000-employee small business size standard. The government will award based on the best value to the Government.